US equities
|
MU
$974.65
▲+4.94%
META
$612.93
▼-1.17%
TSLA
$401.60
▼-1.44%
SPCX
$144.32
▼-2.86%
SNDK
$1,377.96
▲+5.60%
NVDA
$217.97
▲+0.02%
SKHY
$163.35
▲+12.38%
STX
$676.83
▲+1.34%
MU
$974.65
▲+4.94%
META
$612.93
▼-1.17%
TSLA
$401.60
▼-1.44%
SPCX
$144.32
▼-2.86%
SNDK
$1,377.96
▲+5.60%
NVDA
$217.97
▲+0.02%
SKHY
$163.35
▲+12.38%
STX
$676.83
▲+1.34%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about InfraScan
Recent news which mentions InfraScan
Lab Notes: Code Bio makes potential $2B deal; Marinus suffers Covid-related setback
February 25, 2022
Tickers
INNO
Tags
Marinus Pharmaceuticals Inc/
Dana Cipriano
Madhu Natarajan
From
Business Journals